MODDHealthcare · Medical DevicesTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 14 of 100 as at 8 Oct 2026 — in the weakest quartile.
Consensus tells you what everyone already believes. The model scores Modular Medical, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (87): Smaller than most of the companies we track.
Momentum (3): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on MODD, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 21 Mar 2024 | Benchmark | Reiterates | Speculative Buy | $5.00 |
| 21 Mar 2024 | Benchmark | Reiterates | Speculative Buy | — |
| 19 Sept 2023 | Oppenheimer | Reiterates | Outperform | — |
| 30 June 2023 | Benchmark | Reiterates | Speculative Buy | — |
| 19 May 2023 | Oppenheimer | Maintains | Outperform | — |
| 30 Jan 2023 | Benchmark | Maintains | Speculative Buy | — |
| 8 Apr 2022 | Lake Street | Initiates | Buy | — |
| 25 Mar 2022 | Benchmark | Initiates | Speculative Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. MODD appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 8 Oct 2026, Modular Medical, Inc. returned −86.7% against +16.2% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 79% of US stocks
Cheaper than 58% of US stocks
Cheaper than 66% of US stocks
Higher than 32% of US stocks
Higher than 30% of US stocks
Higher than 6% of US stocks
Higher than 2% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Modular Medical, Inc. has a market value of $25.3M and an enterprise value of $18.0M.
Revenue in the twelve months to 30 June 2026: $0.0.
Net income over the same four quarters: −$28.0M.
Free cash flow in the twelve months to 30 June 2026: −$28.0M.
Trailing P/E: −0.2×; forward P/E: −5.2× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Modular Medical, Inc. employs 51 people.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Modular Medical, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Modular Medical announced that CEO Jeb Besser will present at the Webull Emerging & Innovative Companies Webinar on Wednesday, October 14, 2026, at 1:00 p.m.
Why it matters — The presentation is an opportunity for MODD watchers to hear from the CEO about the company as it prepares for the full commercial launch of its next-generation Pivot tubeless patch pump.
Modular Medical, Inc. presented at the IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026, with a transcript of the presentation published by Seeking Alpha. The event provided a platform for the company to communicate its business to investors.
Why it matters — A MODD watcher would care because the presentation offers insights into the company's current positioning and messaging as shared with the investment community.
Modular Medical announced that CEO Jeb Besser will present and host one-on-one meetings at the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026, scheduled for September 15-16, 2026. The presentation is set for Tuesday, September 15 at 1:00 p.m.
Why it matters — A MODD watcher would care because this conference appearance gives the company's CEO a platform to present to and meet directly with investors ahead of the full commercial launch of its Pivot tubeless patch pump.
Modular Medical Inc. announced it has signed a significant contract with a national U.S. pharmacy benefit manager (PBM) for its Pivot insulin pump. The agreement represents a notable commercial milestone for the company.
Why it matters — A national PBM contract could expand market access and reimbursement coverage for Modular Medical's Pivot insulin pump, strengthening the company's commercial position.
Modular Medical announced it has secured a contract with a national U.S. pharmacy benefit manager, making its Pivot tubeless insulin delivery system available through that PBM. The company is preparing for the commercial launch of its Pivot tubeless patch pump.
Why it matters — This contract expands distribution and potential patient access for Modular Medical's Pivot tubeless patch pump ahead of its commercial launch, a key commercial milestone for MODD watchers.
Of the 1 analysts covering Modular Medical, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Modular Medical, Inc. 14 out of 100 across roughly 4,600 US stocks as at 8 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 8 Oct 2026, Modular Medical, Inc. ranks 14 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (87 of 100).
No analyst covering Modular Medical, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MODD are extrapolating price history, which says nothing about the business.
Modular Medical, Inc. returned -86.7% over the 12 months to 8 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Modular Medical, Inc. is a medical device company focused on developing insulin delivery technology for people living with diabetes.
The most recent item we track (Accesswire, 7 Oct 2026): "Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th". Modular Medical announced that CEO Jeb Besser will present at the Webull Emerging & Innovative Companies Webinar on Wednesday, October 14, 2026, at 1:00 p.m.
Modular Medical, Inc. is a medical device company focused on developing insulin delivery technology for people living with diabetes. Its current product lineup centers on insulin pump systems, including the MODD1 two-part patch pump and the Pivot tubeless insulin delivery system, both designed to simplify daily insulin management. The company works within the diabetes care market, addressing the needs of people with type 1 diabetes and insulin-dependent type 2 diabetes. By emphasizing wearable, discreet, and easier-to-use pump formats, Modular Medical aims to make advanced insulin therapy more accessible and practical for a broader range of users. Headquartered in San Diego, California, Modular Medical positions its technology as an alternative to more complex traditional pump systems, with a focus on usability, convenience, and consistent delivery support in clinical and home-care settings.
51 employees · United States · https://www.modularmedical.com
